AlphaGrep UK’s Globus Medical GMED Stock Holding History

AlphaGrep UK’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Buy	+4,401	New	+$374K	0.1%	392
2026 Q1	–	Sell	-2,330	Closed	-$203K	–	842
2025 Q4	$203K	Buy	+2,330	New	+$177K	0.07%	620

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AlphaGrep UK's GMED Position: Q2 2026 in Review

AlphaGrep UK opened a new position in Globus Medical (GMED) in Q2 2026: 4,401 shares worth $348K. The stake represents 0.1% of the portfolio and ranks #392 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in GMED as recently as Q4 2025.

AlphaGrep UK first reported a position in GMED in Q4 2025 and has held it in 2 quarters since. 566 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

AlphaGrep UK held 4,401 shares of Globus Medical worth $348K as of Q2 2026.
Globus Medical was a new AlphaGrep UK position in Q2 2026.
Globus Medical made up 0.1% of AlphaGrep UK's portfolio in Q2 2026, its #392 holding.
AlphaGrep UK first reported a position in Globus Medical in Q4 2025 and has held it in 2 quarters since.
566 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.